Toll-like receptors (TLRs) shape trained immunity, balancing infection responses and chronic inflammation, and TLR agonists are promising immunomodulators for infectious diseases and cancer.

In a recent review article published in the journal Nature Reviews Immunology, researchers synthesize the current knowledge on how having two X chromosomes affects the composition and function of the ...